Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in NXTS held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | GEODE CAPITAL MANAGEMENT, LLC | 50K | $31K | — | 1.441% | 0.00% |
| 2 | XTX Topco Ltd | 22K | $14K | — | 0.629% | 0.00% |
| 3 | Yorkville Advisors Global, LP | 16K | $11K | 0.0% | 0.474% | 0.01% |
| 4 | UBS Group AG | 13K | $9K | +614.2% | 0.379% | 0.00% |
| 5 | VANGUARD FIDUCIARY TRUST CO | 7K | $5K | — | 0.202% | 0.00% |
| 6 | Tower Research Capital LLC (TRC) | 5K | $3K | +363.6% | 0.130% | 0.00% |
| 7 | BFC Planning, Inc. | 12 | $8 | — | 0.000% | 0.00% |
| 8 | MORGAN STANLEY | 5 | $3 | 0.0% | 0.000% | 0.00% |
| 9 | Caitong International Asset Management Co., Ltd | 1 | $1 | — | 0.000% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in NXTS — a direct measure of their conviction.
Filings activity in NXTS during Q1 2026, grouped by how each filer changed its position.
Institutions that opened a new NXTS position in Q1 2026
Institutions that fully closed their NXTS position in Q1 2026
8 quarters of 13F filings · Δ columns show change vs prior quarter
| Quarter | Inst. Holders | Δ Holders | Ownership % | Δ Ownership | Total 13F Value | Δ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 9 | +13% | 3.26% | +3.26 pp | $0M | 19% |
| Q4 2025 | 8 | +0.0% | 0.00% | 0.02 pp | $0M | 82% |
| Q3 2025 | 8 | 47% | 0.02% | +0.02 pp | $0M | +548% |
| Q2 2025 | 15 | 17% | 0.00% | 0.01 pp | $0M | 62% |
| Q1 2025 | 18 | +50% | 0.01% | +0.01 pp | $0M | +539% |
| Q4 2024 | 12 | +20% | 0.00% | +0.00 pp | $0M | 43% |
| Q3 2024 | 10 | +11% | 0.00% | +0.00 pp | $0M | +153% |
| Q2 2024 | 9 | — | 0.00% | — | $0M | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
Institutional ownership and quarterly buying activity across the largest Oncology Biotech peers.
Quick answers to the most common questions about buying NXTS stock.
Based on Q1 2026 13F filings, institutional ownership of Nexentis Technologies Inc. stands at 3.3%, held across 9 reporting institutions.
GEODE CAPITAL MANAGEMENT, LLC is the largest reported institutional holder of NXTS, with approximately 49,840 shares worth $0.00B as of Q1 2026.
No marquee "smart money" managers (Berkshire, Burry, ARK, Tiger Global, Pershing Square, Baupost, etc.) currently appear among the top 25 institutional holders of NXTS.
Our composite Smart Money Score for NXTS is 45 out of 100 (Neutral). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
3 institutions opened new positions in NXTS during Q1 2026, while 4 fully exited. 2 added to existing positions and 2 trimmed.
NXTS institutional ownership rose by 3.26 percentage points quarter-over-quarter, with a net change of +1 holders.
The top 10 institutions account for 100.0% of all reported 13F value in NXTS, and the top 25 account for 100.0%.
Across the largest Oncology Biotech peers, institutional ownership levels are: DMRA (200.0%), FTH (54.5%), LONA (184.4%), KYNB (26.9%), CNSY (4.8%). See the peer comparison table on this page for net buyer activity by company.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.